Combine ECP with Cataract Surgery

Article: Ophthalmology Management | Issue: November 2018 | Author: Michael Patterson, DO Multiple mechanisms are often at play in the production and outflow of aqueous, so glaucoma patients greatly benefit from the simultaneous treatment of both pathways, albeit with different modalities.1 For example, a minimally invasive glaucoma surgery (MIGS) such as the iStent Trabecular Micro-Bypass (Glaukos) treats the outflow and allows the aqueous to egress, while endoscopic cyclophotocoagulation (ECP) (Beaver-Visitec) treats the inflow. Medications could bring about the desired result, but they often create a burden for patients who have compliance issues. (Cont.)